Non-invasive ventilation (NIV) is a way of supporting breathing by delivering pressurized air through a mask or similar device that fits over the nose, mouth, or both. Unlike a ventilator that requires a tube placed into the windpipe, NIV works entirely from the outside. It’s used in hospitals to treat breathing crises and at home for people with chronic respiratory conditions.
How NIV Supports Breathing
When you breathe normally, your diaphragm and chest muscles create negative pressure that pulls air into the lungs. In respiratory failure, those muscles tire out or the lungs themselves can’t exchange gases efficiently. NIV flips the equation by pushing pressurized air into the lungs, reducing the work your breathing muscles have to do.
This positive pressure does several things at once. It opens up collapsed or partially collapsed areas of the lungs, making more lung tissue available for gas exchange. It distributes airflow more evenly, improving the balance between the air reaching the lungs and the blood flowing through them. It also pushes back against fluid trying to seep out of the tiny blood vessels in the lungs, which is especially helpful during heart failure when fluid builds up. The diaphragm doesn’t fully rest during NIV (that would require pressures high enough to cause air leaks and stomach bloating), but its workload drops significantly.
CPAP vs. Bilevel: The Two Main Types
The two most common forms of NIV are CPAP and bilevel pressure support, often called BiPAP.
- CPAP (continuous positive airway pressure) delivers the same steady pressure whether you’re breathing in or out. It’s simpler, widely available, and often the first choice in acute settings like ambulances or emergency departments.
- Bilevel (BiPAP) adjusts pressure depending on your breathing phase: higher pressure when you inhale to help pull air deeper into the lungs, and lower pressure when you exhale so breathing out doesn’t feel like pushing against a wall. This makes it more comfortable for many patients and more effective when carbon dioxide levels are dangerously high.
Both types can be life-saving in the right situation. The choice between them depends on the underlying problem and how severe it is.
When NIV Is Used
The strongest evidence for NIV is in two conditions: flare-ups of chronic obstructive pulmonary disease (COPD) and acute heart failure with fluid in the lungs (cardiogenic pulmonary edema). In COPD flare-ups, pooled data from multiple clinical trials shows NIV reduces the chance of needing a breathing tube from 63% down to 21% and cuts mortality from 25% to 9%. Those numbers represent ICU patients with severe episodes, but even on general hospital wards, NIV roughly halves the likelihood of meeting criteria for intubation.
Acute heart failure with pulmonary edema is the second most common reason NIV is started. European cardiology guidelines recommend it for patients breathing faster than 25 times per minute with oxygen levels below 90%. In this scenario, CPAP is typically used first, while bilevel support may be preferred when carbon dioxide is building up or the patient also has COPD.
NIV is also used for respiratory failure caused by neuromuscular diseases, chest wall problems, obesity-related breathing difficulties, and certain cases of pneumonia or post-surgical respiratory trouble.
Mask Types and Fit
NIV is delivered through an interface that seals against the face. The most common options are nasal masks (covering just the nose) and oronasal masks (covering the nose and mouth). Both deliver ventilation equally well for gas exchange. In a crossover trial of COPD patients, carbon dioxide levels were virtually identical between the two mask types.
The practical differences come down to comfort and sleep. Oronasal masks produced roughly 13% more deep sleep compared to nasal masks, likely because mouth breathing during sleep can cause air to escape through an open mouth with a nasal-only mask. On the other hand, patients perceived less air leakage with nasal masks and often found them more comfortable while awake. When given a choice, patients tended to pick whichever mask caused less breathlessness during use, regardless of what the sleep data showed. Helmets, which enclose the entire head, are a newer option that reduces facial skin injuries but is mainly used in intensive care.
What It Feels Like and Common Side Effects
Discomfort is the most frequently reported issue, affecting 10% to 30% of patients. The sensation of pressurized air being pushed into your lungs can feel unnatural at first, and the tight-fitting mask takes getting used to. Anxiety affects 5% to 15% of patients, particularly early on.
Skin problems are a real concern. About one in four patients develops some degree of facial skin irritation from the mask. The nasal bridge, cheeks, and forehead are most vulnerable. In ICU patients who wear masks for extended periods, the rate of pressure ulcers ranges from 10% to 30%, depending on what preventive steps are taken, such as using padding or rotating mask types.
Gastric insufflation, where pressurized air enters the stomach through the esophagus, happens in up to 10% of cases. This causes bloating, discomfort, and nausea. The more serious risk is that if a patient vomits while wearing the mask, aspiration into the lungs is possible, though this is rare in alert patients. Barotrauma (lung injury from excessive pressure) occurs in less than 1% of cases and is associated with high pressure settings.
When NIV Cannot Be Used
Certain situations make NIV unsafe. Facial trauma or burns prevent a proper mask seal. Active vomiting creates an aspiration risk that NIV would worsen. A fixed blockage in the upper airway won’t respond to positive pressure. And if someone is in cardiac or respiratory arrest, they need a secured airway with a breathing tube, not a face mask.
A longer list of relative contraindications includes recent facial or throat surgery, inability to clear secretions, severe low blood pressure, uncontrolled heart rhythm problems, significantly altered consciousness, and an undrained collapsed lung. In these situations, NIV might still be attempted under close monitoring, but the risks are higher.
How Doctors Know It’s Working
The response to NIV is typically visible within the first one to four hours. Two key signs predict success: a drop in breathing rate and improvement in blood acidity (measured through a blood sample from an artery). If both improve, NIV is very likely to succeed. If neither budges in that window, the medical team will consider moving to a breathing tube.
Clinicians also watch chest and abdominal movement to ensure the machine is synchronizing properly with the patient’s breathing. Oxygen levels, carbon dioxide levels, and overall alertness are tracked closely during the initial period.
Hospital NIV vs. Home NIV
In the hospital, NIV is a crisis intervention. It’s started when breathing fails acutely and discontinued once blood gas levels normalize and the patient’s condition improves overall. But some people need NIV long-term at home, particularly those with COPD, neuromuscular diseases, or obesity-related respiratory failure.
The transition to home use typically happens after the patient is medically stable, with normal blood acidity (pH above 7.35) and no active flare-up. A common trigger for starting home NIV is two or more hospitalizations in a year for breathing crises, especially life-threatening ones, or difficulty being weaned off a ventilator after a hospital stay. Settings for the home machine are adjusted when the patient is in a stable baseline state, not during an acute episode.
Getting started on home NIV involves an acclimatization period at a center experienced in long-term ventilation. Patients learn how to use and maintain the equipment, troubleshoot mask fit, and recognize signs that something isn’t right. For many people, home NIV becomes a nightly routine that reduces hospitalizations and improves quality of life over time.